Holen Sie sich die Stockscreener-App
60.43
3.80%
2.21
Vorhandelsmarkt:
60.12
-0.31
-0.51%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
Freestone Capital Holdings LLC Purchases 7,242 Shares of DexCom, Inc. $DXCM - MarketBeat
Building trade automation scripts for DexCom Inc.July 2025 Breakouts & Weekly Setup with High ROI Potential - newser.com
Is DexCom Inc. (DC4) stock cheap by valuation metricsEntry Point & Safe Capital Growth Trade Ideas - newser.com
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Lost Money on DexCom, Inc. (DXCM)? Urged to Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit - PR Newswire
DexCom (DXCM): UBS Lowers Price Target to $95, Maintains 'Buy' R - GuruFocus
DexCom Faces Class Action Over Alleged Investor Deception - TipRanks
DXCM CLASS ACTION LAWSUIT: A Securities Fraud Class Action - GlobeNewswire
DexCom Stock Rises 3.7% on November 3, 2025 | DXCM NewsNews and Statistics - IndexBox
DexCom (DXCM) Stock Is Up, What You Need To Know - TradingView
DexCom Growth Outlook Likely Sustainable, UBS Says - MarketScreener
UBS Adjusts DexCom Price Target to $95 From $106, Maintains Buy Rating - MarketScreener
Truist Securities Reiterates Buy Rating on DexCom (DXCM) Despite - GuruFocus
Has DexCom Inc. found a price floorRisk Management & Advanced Technical Signal Analysis - newser.com
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is DexCom Inc. (DC4) stock a top pick for value investorsPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
Can DexCom Inc. stock maintain operating marginsInsider Selling & Stock Portfolio Risk Management - newser.com
Will DexCom Inc. stock continue dividend increasesQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
Can DexCom Inc. (DC4) stock hit consensus price targetsJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Will DexCom Inc. stock maintain momentum in 2025Inflation Watch & Weekly Momentum Stock Picks - newser.com
What does recent volatility data suggest for DexCom Inc.2025 Big Picture & Verified Entry Point Signals - newser.com
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
FY2025 EPS Estimates for DexCom Increased by Leerink Partnrs - MarketBeat
What MACD and RSI say about DexCom Inc.Market Volume Summary & Community Consensus Stock Picks - newser.com
What is William Blair's Forecast for DexCom FY2025 Earnings? - MarketBeat
Is DexCom Inc. stock attractive for passive investors2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Will breakout in DexCom Inc. lead to full recoveryIPO Watch & Advanced Swing Trade Entry Plans - newser.com
DexCom Inc. stock chart pattern explainedMarket Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Is DexCom Inc. (DC4) stock a buy for dividend portfoliosWall Street Watch & Daily Oversold Bounce Ideas - newser.com
Can DexCom Inc. stock sustain free cash flow growthEarnings Trend Report & Advanced Swing Trade Entry Alerts - newser.com
Will a bounce in DexCom Inc. offer an exitInflation Watch & Breakout Confirmation Alerts - newser.com
DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)Contact Kessler Topaz Meltzer & Check, LLP - The Malaysian Reserve
Earnings Beat: DexCom, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Geneva Capital Management LLC Increases Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Acquired by Strs Ohio - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q3 2025 Earnings Call Transcript - MSN
Is DexCom Inc. (DC4) stock supported by free cash flowQuarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com
DexCom (NASDAQ:DXCM) Price Target Lowered to $75.00 at JPMorgan Chase & Co. - MarketBeat
What catalysts could drive DexCom Inc. stock higherWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
DexCom Sees Unusually Large Options Volume (NASDAQ:DXCM) - MarketBeat
DexCom (DXCM): Net Margin Slides to 13.3%, Testing Bulls’ Profitability Narratives - Yahoo Finance
Class Action Announcement for DexCom, Inc. (DXCM): Kessler - GlobeNewswire
Royal Bank Of Canada Cuts DexCom (NASDAQ:DXCM) Price Target to $85.00 - MarketBeat
DexCom (NASDAQ:DXCM) Shares Gap Down After Analyst Downgrade - MarketBeat
DexCom (NASDAQ:DXCM) Price Target Lowered to $85.00 at BTIG Research - MarketBeat
DexCom’s Shares Drop Despite Beating Earnings Expectations - Finimize
Fisher Funds Management LTD Sells 339,084 Shares of DexCom, Inc. $DXCM - MarketBeat
Hantz Financial Services Inc. Trims Stake in DexCom, Inc. $DXCM - MarketBeat
Envestnet Asset Management Inc. Increases Stock Position in DexCom, Inc. $DXCM - MarketBeat
Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025 - ADVFN
What MACD trends signal for DexCom Inc. (DC4) stockQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - newser.com
Citigroup Maintains DexCom (DXCM) Buy Recommendation - Nasdaq
JP Morgan Maintains DexCom (DXCM) Neutral Recommendation - Nasdaq
DexCom (DXCM) Margin Compression Tests Bullish Narratives Despite Strong Growth and Value Signals - Sahm
0.69%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):